Viewing Study NCT01934634


Ignite Creation Date: 2025-12-25 @ 2:37 AM
Ignite Modification Date: 2026-02-28 @ 6:39 AM
Study NCT ID: NCT01934634
Status: UNKNOWN
Last Update Posted: 2015-11-10
First Post: 2013-08-29
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase I Trial of LCL161 and Gemcitabine Plus Nab-Paclitaxel in Metastatic Pancreatic Cancer
Sponsor: US Oncology Research
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module